Drug Combination Details
General Information of the Combination (ID: C37534) | |||||
---|---|---|---|---|---|
Name | Wogonin NP Info | + | Oxaliplatin Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Stomach cancer
[ICD-11: 2B72]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Phosphorylation | JNK1 | Molecule Info |
Pathway MAP
|
|
Down-regulation | Phosphorylation | ULK1 | Molecule Info |
Pathway MAP
|
||
Biological
Regulation |
Up-regulation | Peroxynitrite formation | ||||
In-vitro Model | BGC-823 | CVCL_3360 | Gastric cancer | Homo sapiens | ||
In-vivo Model | Approximately 300 cells for the CM-Dil-labeled BGC-823 cells were injected into the yolk sac per zebrafish embryo using a microinjector. | |||||
Experimental
Result(s) |
Wogonin exacerbates the cytotoxic effect of oxaliplatin by inducing nitrosative stress and autophagy in human gastric cancer cells. |
References | ||||
---|---|---|---|---|
Reference 1 | Wogonin exacerbates the cytotoxic effect of oxaliplatin by inducing nitrosative stress and autophagy in human gastric cancer cells. Phytomedicine. 2018 Jan 15;39:168-175. |


